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Abstract
LRRK2 plays an important role in Parkinson’s disease (PD), but its biological functions are largely unknown. Here, we cloned
the homolog of human LRRK2, characterized its expression, and investigated its biological functions in zebrafish. The
blockage of zebrafish LRRK2 (zLRRK2) protein by morpholinos caused embryonic lethality and severe developmental defects
such as growth retardation and loss of neurons. In contrast, the deletion of the WD40 domain of zLRRK2 by morpholinos
targeting splicing did not induce severe embryonic developmental defects; rather it caused Parkinsonism-like phenotypes,
including loss of dopaminergic neurons in diencephalon and locomotion defects. These neurodegenerative and locomotion
defects could be rescued by over-expressing zLRRK2 or hLRRK2 mRNA. The administration of L-dopa could also rescue the
locomotion defects, but not the neurodegeneration. Taken together, our results demonstrate that zLRRK2 is an ortholog of
hLRRK2 and that the deletion of WD40 domain of zLRRK2 provides a disease model for PD.
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Introduction
Parkinson’s disease (PD) is a common neurodegenerative
disorder characterized by the selective loss of dopaminergic
neurons of the substantia nigra pars compacta (SNpc) and
movement symptoms, including resting tremor, rigidity and
postural instability [1]. The vast majority of PD patients are
idiopathic, but a small number of patients show a familial
inheritance where mutations in a-synuclein, Parkin, DJ-1,
ubiquitin-C-hydrolase-L1 (UCHL1) or Leucine-rich repeat kinase
2 (LRRK2) play an important role [2,3].
Of the identified disease genes for PD, mutations in LRRK2 are
the most prevalent in both familial and sporadic PD patients
[4–6], and show an interesting diversity in terms of population
distribution as well as functional impact. For example, G2019S
variant within the kinase domain was found to be a high-penetrate
gain-of-function mutation (associated with enhanced kinase
activity); it appears to be the most common mutation in the
majority of the populations studied except Asian ones [7–9]. In
contrast, G2385R variant within the WD40 domain results in a
loss-of-function mutation (associated with the reduced kinase
activity) and is a common susceptibility allele in Asian populations,
but absent in Caucasians [10,11]. The diverse spectrum of
pathogenic mutations within the multiple domains of LRRK2
protein (see below) and the complex mechanisms by which these
mutations influence the development of PD suggest that LRRK2
may be a master regulator of the disease development [12].
LRRK2 is therefore not only clinically important to link the
familial and sporadic forms of PD, but also biologically significant
for understanding the etiology of the disease [13].
The biological function of LRRK2 is, however, largely
unknown. Human LRRK2 (hLRRK2) encodes an unusually large
protein composed of multiple functional domains, including
armadillo repeats, ankyrin repeats, two enzymatic S/T kinase
and Roc GTPase domains, COR and WD40 domains (as the
dimerization motif), indicating that LRRK2 is a complex
multifunctional protein [14,15]. The functional studies of LRRK2
were largely carried out by over-expressing either the wild-type or
mutant allele of the MAPKKK and ROC domains of hLRRK2 in
in vitro and in vivo model systems [16]. These transgenic studies
suggested that the hyperactive kinase activity of LRRK2 may be
cytotoxic and cause neurodegeneration. However, over-expression
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the same mutant effect, as demonstrated in rat studies [17], raising
a question on how much can be inferred from such ‘gain-of-
function’ analysis of mutant alleles in understanding the normal
function of LRRK2. When measuring the kinase activity of
LRRK2 mutations using moesin as substrate [18], the most
frequent mutation, G2019S, is the only one showing stimulated
kinase activity. Hence, the mechanism by which LRRK2 mutation
induces PD is more complex than previously imagined and is not
only due to an increase in LRRK2 kinase activity. Analysis of loss-
of-function mutations in Drosophila (dLRRK2) revealed conflicting
findings; and it was not clear whether the disruption of dLRRK’s
function caused parkinsonism-like neurodegeneration and loco-
motive defects in this model system [19,20]. So far, there are no
reports on the function of WD40 or other domains in vertebrate
models, such as the mouse or rat and the decreased kinase model
for LRRK2 is very limited.
In this study, we performed the first in vivo loss-of-function study
of LRRK2 in zebrafish. We cloned the zebrafish homolog of
human LRRK2 and performed a series of molecular and genetic
analyses to characterize its expression and biological functions,
particularly the role of the WD40 domain, in embryonic and
neuronal development.
Results
Molecular cloning of the zebrafish ortholog of hLRRK2
Through a TBLASTN analysis of hLRRK2 protein sequence
against zebrafish cDNA sequences and a subsequent TBLASTX
analysis of the identified zebrafish cDNA sequences against human
cDNA sequences, we identified XM_682700 as the zebrafish
homolog of hLRRK2. To clone the full length transcript of
zLRRK2, we performed further RACE analysis using mRNAs
isolated from the brain of adult fish and identified a 9168 bp
transcript carrying both start and stop codons. The size of this
transcript matched the zlrrk2 mRNA detected by Northern analysis
(Figure 1B). This 9168 bp transcript consists of 51 exons, spanning
118 kb genomic sequences (chr25:37299901–37361611, UCSC
Genome Browser, Dec 2008) and encodes a protein of 2533 amino
acid residues (Text S1). This experimentally cloned full length
transcript is different from the ensembl predicted cDNA of 7410 bp
that consists of 59 exons and encodes a protein with 2470 amino acid
residues. The zLRRK2 protein contains all the functional domains of
the hLRRK2 protein. There is a high degree conservation of amino
acid sequences between the zLRRK2 and hLRRK2 proteins, with
the highest conservation within the kinase domain (71%) (Figure 2).
A phylogenetic analysis (Figure S1) revealed that the zLRRK2
protein was clustered together with the hLRRK2 protein as well as
the LRRK2 proteins of other animal species.
Analysis of expression profile of zLRRK2 in zebrafish
A temporal expression analysis by quantitative RT-PCR (qRT-
PCR) (Figure 1A) indicated that the maternal mRNA of zlrrk2
could be detected at the pre-MBT (mid blastula transition: from
one cell to sphere) stages and was then degraded by the beginning
of the gastrula stage. The zygotic expression of zlrrk2 was first
detectable at the tail bud stage (the last stage of gastrulation) and
increased gradually during the segmentation and pharyngula
stages, reaching a peak around 24 hours post fertilization (hpf).
After a short period of reduction, the expression of zlrrk2 increased
again through the hatching and larval stages up to, at least, 10
days post fertilization (dpf). At both 24 hpf and 6 dpf, a strong
expression of zlrrk2 could be detected in the brain by whole mount
in situ hybridization (WISH) analysis, and zlrrk2’s expression in the
brain is ubiquitous (Figure 1E). In adult fish (older than three
months), zlrrk2 mRNA was detected in the brain, muscle, ovary
and gut by Northern blot and qRT-PCR analyses (Figure 1B and
1C), but full-length zLRRK2 protein was predominantly detected
in brain by Western blot (Figure 1D).
Knockdown of zLRRK2 protein expression by
morpholinos caused a severe embryonic defect and a
loss of diencephalon tyrosine hydroxylase-positive (TH+)
neurons
Microinjection of morpholinos targeting the ATG start site into
embryos effectively abolished the expression of zLRRK2 protein, as
determined by Western blot analysis (Figure S2 and Figure S3A).
Knockdown of zLRRK2 expression resulted in severe embryonic
lethality (,90% of 64 embryos examined) within 3 dpf. The
surviving morphants showed developmental retardation, such as
slow growth, reduced brain size and heart edema compared to the
wild type fish (Figure S3). WISH analysis showed a loss of TH+
neurons in the diencephalon of the surviving morphants (Figure
S3B), which was consistent with the reduced level of tyrosine
hydroxylase detected by the Western blot analysis (Figure S3A).
Both heart edema and TH+ neuron loss phenotypes are
morpholino concentration-dependent and can be partially rescued
by over-expression of human LRRK2 (Figure S3 and Figure S4)
(zLRRK2 was not used for the rescue, because its expression will be
blocked by ATG morpholinos). However, due to the developmental
retardation, it is not clear whether the loss of TH+ neurons in the
diencephalon is an indication for a specific role of zLRRK2. The
severe embryonic defect of the zLRRK2 knockdown also prevented
us from studying its impact on locomotive movement.
WD40 domain deletion caused neurodegeneration,
including the loss of dopaminergic (DA) neurons and
axon tract disorganization in brain
It has been shown that G2385R variant within the WD40
domain was associated with a very moderate risk for PD
development [21]. We therefore hypothesize that the deletion of
WD40 domain may lead to a weaker phenotype than the
Author Summary
Parkinson’s disease (PD) is a degenerative disease of the
brain (central nervous system) that often impairs motor
skills, speech, and other functions. PD was long thought to
be caused by environmental factors, but the discovery of
several gene mutations in the patients (mostly with familial
form of PD) clearly demonstrated the involvement of
genetic factors in the development of PD. Among the
identified genes, LRRK2 was discovered to be one of the
most important genetic causes of PD. The biological
function of LRRK2 was, however, largely unknown. In this
study, we studied the function of LRRK2 in zebrafish by
blocking the normal function of LRRK2. The zebrafish
showed features of neurodegeneration and locomotion
defects, similar to those of PD patients. The defects of the
fish could be rescued by expressing the normal protein of
LRRK2, and the locomotion defect could also be rescued
by the administration of L-dopa that is commonly used for
treating PD patients. We have therefore developed a
zebrafish model for PD that can be used for understanding
the mechanism underlying the development of PD and will
be helpful for future screening of new drugs to treat PD.
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specific role of zLRRK2 in neurodevelopment and locomotive
movement. To delete the WD40 domain, we designed morpho-
linos that specifically interrupted the splicing of the 45th exon of
zlrrk2 and consequently introduced a pre-mature stop codon just
upstream of the WD40 domain (Figure S5A). Delivery of this
splicing-blocking morpholinos into embryos caused a production
of truncated zlrrk2 mRNA without the WD40 domain (zLRRK2-
Figure 1. Expression profiling of lrrk2 in zebrafish. (A) Quantitative RT–PCR analysis of zlrrk2 mRNA expression from 1 cell stage to 10 dpf. (B–D)
Northern blot analysis (B), quantitative RT–PCR (C), and Western blot analyses (D) of zLRRK2 expression in gut, muscle, ovary, and brain of adult fish.( E )
In situ hybridization of zlrrk2 mRNA at 24 hpf and 6 dpf stage. For 6 dpf stage, cryo-sectioning was performed in the position labeled as 1 and 2.
doi:10.1371/journal.pgen.1000914.g001
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(Figure S5B and S5C). As hypothesized, zLRRK2-DWD40
morphants showed a largely normal embryonic development, at
least up to 7 dpf, without any distinguishable morphological
defects, except a mild blood accumulation between the swim-
bladder and yolksac (Figure S6). Western blot analysis of whole
fish lysate of zLRRK2-DWD40 morphants (3 dpf) (Figure 3A and
Figure S2) showed significant loss of full-length (280 KD)
zLRRK2 protein and TH protein expression. The reduction of
TH expression was also confirmed by qRT-PCR analysis (Figure
S5D). Consistently, the WISH analysis (at 3 dpf) showed a loss of
TH+/DAT+ DA neurons in the diencephalon of the zLRRK2-
DWD40 morphants (Figure 3B). As expected, the phenotypes of
the zLRRK2-DWD40 morphants are morpholino concentration-
dependent (Figure S4).
To further investigate the impact of zLRRK2-DWD40 on
neurodevelopment, we microinjected the zLRRK2-DWD40
morpholinos into the embryos of the Tg(DeltaD:GAL4/UAS:-
Kaede) line [22], where neurons are labeled by Kaede expression
(driven by detlaD promoter). At 18 somite stage of embryonic
development, no obvious neuron cell loss could be observed in the
DWD40 morphants (compared to the wild-type fish) (Figure 3C).
At 6 dpf, the forebrain and hindbrain of the morphants appeared
to be normal and indistinguishable from the control siblings, but
the midbrain, particularly the optic tectum of the morphants
contained far fewer neurons than the control siblings (Figure 3C).
Using the TUNEL assay, we found an enhanced apoptosis
throughout the zLRRK2-DWD40 morphants (Figure 3D). We
also stained axonal microtubules using an acetylated-tubulin
antibody and found a reduction and disorganization of axon
tracts, most prominently in the optic tectum of the zLRRK2-
DWD40 morphants (Figure 4). These results indicated that the
deletion of the WD40 domain causes the loss of neurons and the
reduction and disorganization of axon tracts in the brain,
including the DA loss in the diencephalon of the morphants.
Over-expression of either wild-type zLRRK2 or hLRRK2
(Figure S7) could rescue both the DA neuron loss (Figure 3B,
Figure 5A and 5B) and axon tract disorganization (Figure 4) of the
zLRRK2-DWD40 morphants, confirming that the neurodegen-
erative phenotypes of the zLRRK2-DWD40 morphant was a
specific effect of the WD40 domain deletion due to splicing-
blocking morpholinos, instead of off-target effect or unspecific
toxicity of morpholinos. Furthermore, the successful rescue of the
neurodegenerative phenotype by wild-type hLRRK2 confirmed
zLRRK2 to be the functional ortholog of hLRRK2.
The WD40 domain deletion of zLRRK2 caused a
locomotion defect
To investigate the locomotion behavior of the zLRRK2-
DWD40 morphants, we measured the swimming distance of
larval fish within time windows of 30 seconds. As shown in
Figure 6, the zLRRK2-DWD40 morphants moved much smaller
distances than the wild-type fish. Like the neurodegenerative
defects, this reduced swimming activity could be rescued by over-
expressing either zLRRK2 or hLRRK2 (Figure 6 and Figure S8).
Intriguingly, this reduced swimming activity of zLRRK2-DWD40
morphants could also be rescued by the administration of Levo-
dopa (L-dopa), a compound that is widely used to treat PD
(Figure 6 and Figure S8). The administration of L-dopa, however,
did not rescue the neurodegenerative phenotype of the morphants,
as demonstrated by TH labeling (Figure 3B, Figure 5A and 5B).
Over-expression of human LRRK2 G2019S and G2385R
mutant alleles in zebrafish
In addition to the investigation of the WD40 deletion, we also
investigated the impact of the over-expression of human LRRK2
G2019S and G2385R mutant alleles in zebrafish. The over-
expression of both the mutant alleles could induce a similar blood
accumulation between the swim bladder and yolk sac as the
zLRRK2-DWD40 deletion and a mild loss of TH+ cell compared
to wild-type (Figure S4 and Figure S9). Furthermore, unlike the
wild-type zLRRK2 and hLRRK2, both hG2019S and hG2385R
alleles could only partially rescue the loss of TH+ neurons in the
zLRRK2-DWD40 morphants (Figure 5C).
Discussion
In this study, we provide strong evidence that zLRRK2 is an
ortholog of hLRRK2. The proteins of zLRRK2 and hLRRK2
show a conservation of amino acid sequence and share an identical
domain structure. Phylogenetically, zLRRK2 is clustered together
with hLRRK2, instead of hLRRK1, as well as the LRRK2
proteins of other animal species. Finally, the successful rescue of
the defects of zLRRK2 morphants, in terms of both neurodegen-
eration and swimming abnormality, by over-expressing hLRRK2
mRNA, provides the most convincing evidence for a functional
conservation of LRRK2 between zebrafish and human.
zLRRK2 shows a dynamic expression profile in zebrafish.
During embryonic development, zLRRK2 transcript is mainly
restricted to the brain, but demonstrating ubiquitous expression
within brain, as observed in mouse, rat and human brains [23,24].
In adult fish, zlrrk2 mRNA was expressed in multiple tissues or
organs. Western blot analysis (using an antibody against the WD40
domain), however, showed a rather restricted expression of
zLRRK2 protein in the brain. Together with the previous finding
that the LRRK2 protein isolated from transgenic mouse brain
showed a higher kinase activity than from transgenic mouse lung
or transfected cultured cells [25] and the suggestion that hLRRK2
has several splicing forms (AceView [26]); the differential
expression patterns of zLRRK2 mRNA and protein in various
tissues may suggest a complex mechanism for regulating zLRRK2
splicing and expression.
Figure 2. Conservation of amino acid sequences and functional domains of LRRK2 between zebrafish and human.
doi:10.1371/journal.pgen.1000914.g002
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The involvement of zLRRK2 in neurodevelopment is first
suggested by the retarded brain development and the loss of
TH+ neurons in the zLRRK2 ATG morphants and further
evidenced by the neurodegenerative phenotypes of the
zLRRK2-DWD40 deletion. The zLRRK2-DWD40 deletion
caused a significant loss of DA neurons in the diencephalon,
and other types of neurons are also likely affected. Interest-
ingly, our preliminary study showed that the zLRRK2-
DWD40 deletion had a rather limited impact on the
development of neurons during early embryonic development.
Considering that, 1) zLRRK2 shows a ubiquitous expression in
the brain, 2) the zLRRK2-DWD40 deletion leads to an
increased apoptosis activity across the brain, and 3) the
midbrain, particularly the optic tectum of zebrafish is very
stress-sensitive, the loss of neurons in the zLRRK2-DWD40
Figure 3. Phenotype of neuronal loss in LRRK2 DWD40 morphants. (A) Western blot analysis at 2 dpf and 3 dpf confirming the knockdown
effect of zLRRK2 wild-type protein expression as well as the decreased TH protein expression in WD40 deletion morphant. Adult brain protein was
used as positive control, and the ATG morphant at 3 dpf was used as negative control. The quantified results are shown in Figure S2. (B) WISH
analysis at 3 dpf showing that WD40 domain deletion caused decreased TH and DAT expressions in WD40 deletion morphant, but without significant
brain developmental retardation. (C) Uninjected (left) and WD40 deleted zebrafish expressing Kaede under the deltaD promoter. While neuron
numbers is not much changed at 18 somite stage, there are fewer neurons in the midbrain of these 6 dpf fish, as indicated by the arrowheads.
***P,0.001, n.s.: not significant (unpaired Student’s t-test). (D) Cell apoptosis assay of uninjected (left) and WD40 delete zebrafish embryos.
doi:10.1371/journal.pgen.1000914.g003
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instead of the interruption of normal neuronal development.
The loss of DA neurons in zLRRK2-DWD40 deletion likely
happens as a result of a rather broad neurodegeneration within
several regions of the brain. We speculate that LRRK2 may be
important for neuron survival and thus play a more prominent
role in neural maintenance, rather than development of
neurons. The interruption of normal LRRK2 function may
cause neurons to become more sensitive to factors that might
trigger cell death.
The zLRRK2-DWD40 deletion also caused a significant
reduction and disorganization of axon tracts, more prominently
in the midbrain. This is consistent with the previous finding from
transgenic mouse study that LRRK2 is involved in neurite growth
[27]. Since LRRK2 interacts with microtubule through Roc
domain [12] and the WD40 domain can bind to the Roc domain
[28], the reduced and disorganized axon tracts in the midbrain of
the zLRRK2-DWD40 morphants may be due to an interruption
of the microtubule cytoskeleton [29]. This would be consistent
with the well established requirement for microtubules in axon
outgrowth. Our result has also supported the recent hypothesis
that Parkinsonism may be due to a disorganized ‘microtubule
Figure 4. Analysis by acetylated tubulin staining of embryos at
6 dpf. Compared to the uninjected embryo, the WD40 deletion
morphant has reduced and disorganized axon tracts in the midbrain of
zebrafish. This phenotype could be rescued by over-expressing either
zLRRK2 (WD40+zLRRK2) or hLRRK2 (WD40+hLRRK2) mRNA. **P,0.01,
***P,0.001 (unpaired Student’s t-test).
doi:10.1371/journal.pgen.1000914.g004
Figure 5. WISH Analysis of the loss of TH+ cell in WD40
morphant and its rescue by over-expressing wild-type zLRRK2
or hLRRK2 as well as hLRRK2 mutant alleles. (A) WISH analysis at
3 dpf shows the decreased TH expression in WD40 deletion morphant
as well as the successful rescue by over-expressing either zLRRK2 or
hLRRK2. The analysis also shows the decreased TH expression in the fish
with over-expression of wild-type zLRRK2 and hLRRK2. This neurode-
generative phenotype could not be rescued by the treatment of L-
dopa. (B) Quantification of rescue effect of zLRRK2 or hLRRK2 on TH+
cell loss in WD40 morphant. ***P,0.001 (unpaired Student’s t-test). (C)
Quantification of rescue effect of hG2019S or hG2385R on TH+ cell loss
in WD40 morphant. **P,0.01, ***P,0.001 (unpaired Student’s t-test).
doi:10.1371/journal.pgen.1000914.g005
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motor [30] or perhaps microtubule. However, further study will be
needed to elucidate whether the reduced and disorganized axon
tracts truly reflects the interrupted ‘microtubule railroad’ system
and thus causes neurodegeneration.
This is the first demonstration of the role of the WD40 domain
of LRRK2 in neural development and/or neural maintenance.
The WD40 domain is known to mediate protein-protein
interaction in many contexts, such as signal transduction,
transcription regulation, cell cycle control, apoptosis and cytoskel-
eton assembly [31]. The WD40 domain has been suggested to play
a crucial role in LRRK2 self-interaction and autophosphorylation,
which regulates the kinase activity of LRRK2 [28]. The deletion of
the WD40 domain causes a partial reduction in kinase activity in
vitro, which could be restored to a normal level by the over-
expression of the gain-of-function mutation R1441C [32]. We
have previously shown that the G2385R risk variant in the WD40
domain increases neuronal apoptosis under cellular stress [33],
providing further support for the functional role of WD40 domain.
However, the different phenotypic impact of blocking the kinase
activity of LRRK2 (by knocking-down the protein expression) and
deleting the WD40 domain suggests that LRRK2 may influence
the neurodevelopment through other mechanisms beyond the
modification of its kinase activity.
We have demonstrated a locomotion defect in the zLRRK2-
DWD40 morphant. More importantly, we confirmed that the
locomotion defect likely happens as a direct result of the dopamine
insufficiency (due to the loss of DA neurons), since the defect can
be rescued by supplementing dopamine through the administra-
tion of L-dopa. The administration of L-dopa did not rescue the
loss of DA neurons in the diencephalon of zLRRK2-DWD40
morphant. This is consistent with the therapeutic effect of L-dopa
in treating human PD condition where the treatment can only
offer a temporary relieve of clinical symptoms, but cannot restore
the degeneration of DA neurons [34]. The morphant phenotypes
of the zLRRK2-DWD40 deletion seem to closely mimic the
human condition of PD at both molecular and physiological levels.
In addition, our preliminary study has shown that the over-
expression of human point mutations, such as G2019S and
G2385R, shows a similar impact on neural development as the
WD40 deletion in zebrafish. This is consistent with the dominant
effect of human point mutations, such as G2019S, to induce PD-
like phenotypes in other animal models. Furthermore, MPTP
treatment was shown previously to trigger the similar degeneration
of DA neurons and locomotion behavior defects in zebrafish as in
human [35,36]. Taken together, these studies have demonstrated
that zebrafish can be used for studying PD-related neurodegen-
eration, and the deletion of WD40 domain in zebrafish provides a
potential disease model for PD.
It is noteworthy to point out that the neuron loss of zLRRK2-
DWD40 can be observed as early as in the late stage of embryonic
development. As a limitation of this model, the early-onset
phenotype of zLRRK2-DWD40 does not fully recapitulate the
late-onset PD phenotype in human. This difference may, at least
partially, due to the fact that the knock-down effect of splice-
blocking morpholino could be up to 90% in zebrafish, whereas PD
patients usually carry heterozygous point mutations of LRRK2.
Consequently, the early-onset phenotype of zLRRK2-DWD40
may be due to more severe mutational effect of WD40 deletion
than heterozygous point mutations in human. Furthermore,
although the molecular function of LRRK2 is conserved between
zebrafish and human, the neuronal system, including dopaminer-
gic one, may not be fully conserved between two species. As a
consequence, mutations of functionally conserved LRRK2 may
show partially different phenotypes. It is not truly unexpected
because it is rather uncommon for animal models to recapitulate
the full phenotype of human disease.
Several animal models for PD were developed in recent years.
DJ-1 knockout mice show decreased motor functions, increased
striatal dopamine level without the loss of DA neurons [37,38] and
increased sensitivity to MPTP and oxidative stress [39]. Consis-
tently, the knockdown of DJ-1 expression in zebrafish did not
result in a loss of DA neurons, unless under the exposure to pro-
oxidant hydrogen peroxide and the proteasome inhibitor MG132
[40]. In PINK1 knockdown [41] or knockout mice [42], there
were no changes in striatal dopamine level, nigral DA neurons
numbers and motor activity. In Parkin knockout mice, mutants
with the deletion of exon2 [42] showed no abnormalities
compared to wild-type mice in terms of the nigral DA neurons
numbers and motor activity, while the mutants with the deletion of
exon3 [43] showed behavioral deficits, but without DA neurons
loss. The conditional LRRK2 G2019S model [27] was reported to
have no obvious neuropathological or motor abnormalities at 12
months of age. Over-expression of UCH-L1 in zebrafish did not
result in a discernible phenotypic effect [44]. Therefore, the
Figure 6. Analysis of locomotive movement by measuring the
swimming distance in 30 seconds. The WD40 morphants swam
much less distance than the wild-type fish. This locomotive defect could
be rescued by over-expressing either zLRRK2 (WD40+zLRRK2) or
hLRRK2 (WD40+hLRRK2) mRNA as well as by L-dopa treatment (WD40 +
L-dopa). Each bar indicates the distance of an individual fish moved
within 30 seconds. Each red dot (connected by red line) indicates the
average distance of each of the five fish pools moved within 30
seconds, and the bar represents the SD of distance. *P,0.05, **P,0.01,
n.s.: not significant (unpaired Student’s t-test). It is noticeable that one
of the DWD40 fish showed a very different phenotype from the rest.
The distinct phenotype of this ‘outlier’ fish was likely due to either the
failure or in-efficient knock-down effect by morpholino. The rescue
effect by over-expressing hLRRK2 became statistically significant
(P=0.03) when the possible outlier of the DWD40 group (black arrow)
is removed from the statistical analysis.
doi:10.1371/journal.pgen.1000914.g006
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the progressive loss of nigrostriatal dopaminergic neurons and
motor defects. In Drosophila, the expression of wild-type and
mutant forms of human a-synuclein lead to a progressive DA
neuron loss [45], and the loss could be suppressed by the over-
expression of parkin [46]. Drosophila parkin-null mutants also
showed motor deficits [47] and DA neuron degeneration [48,49].
Recently, Lee et al. found that the loss of Lrrk2 in Drosophila lead to
impaired locomotive activity and degeneration of DA [20].
However, Wang et al’s study did not confirm this observation
and instead found an increased sensitivity to oxidative stress [19].
The over-expression of hLRRK2 wild-type or G2019S mutant
allele in Drosophila resulted in loss of DA neurons, locomotor
dysfunction and early mortality, which could be rescued by the
administration of levodopa [50]. Although this invertebrate model
recapitulates several features of human PD, a recent study showed
that dLRRK2 is not an ortholog of hLRRK2 [51], dampening the
relevance and importance of this Dorsophila LRRK2 model for PD.
In summary, we have demonstrated that zLRRK2 is an
ortholog of hLRRK2. As a vertebrate model, the zLRRK2-
DWD40 morphant recapitulates some key molecular, physiolog-
ical and behavioral hall-marks of PD. Together with other animal
models, this potential vertebrate model provides opportunities to
investigate the biological mechanisms underlying the development
of PD. The fact that the locomotion defect of the zLRRK2-
DWD40 morphant can be ‘treated’ by L-dopa also raises the
possibility that this zebrafish model may be used for screening new
drugs to treat PD.
Materials and Methods
Molecular cloning of full-length zebrafish LRRK2 cDNA
A TBLASTN analysis of the human LRRK2 protein against
zebrafish cDNA sequences yielded two hits, XM_682700 and
XM_682192. Through reciprocal TBLASTX, we found that
XM_682700 was the possible homolog of human LRRK2
(hLRRK2), whereas XM_682192 was the possible homolog of
human LRRK1. As indicated, XM_682700 is a predicted cDNA
of zebrafish LRRK2 (zLRRK2) with about 6 kb sequences. To
verify whether it is a true coding gene, we blasted this sequence
against the genome of zebrafish and identified 6 EST sequences
(BI884532, EB935015, BI882500, AL918398, BQ258400 and
CD758533). To identify the full length transcript of zLRRK2, we
performed RACE analysis by using mRNA isolated from the brain
of adult fish and the sequence of BI884532 (most 59 end) for
designing the primer of 59-RACE and AL918398 (most 39 end) for
designing the primer of 39-RACE. Likewise, using the sequences of
the same two ESTs, a pair of primers was designed to amplify the
middle part of the zLRRK2 transcript. After cloning and
sequencing, we identified a 9168 bp transcript carrying both start
and stop codons.
59 RACE and 39 RACE were performed by using the
GeneRacer Kit (Invitrogen, USA) according to manufacturer
instructions. Gene Specific Primer for 59 end is 59 CTGCATTT-
CAGCAACACAGG 39 and Gene Specific Primer for 39 end is 59
AAGTCCAGCGTGTAGCTGAGCGTGGAAATG 39.
Quantitative RT–PCR
qRT-PCR was performed with HIGH CAPACITY CDNA
REVERSE TRANSCRIPTION KIT and SYBR Green 1 PCR
Master Mix. Gene specific primers are 59GACTCCGAGGCGA-
TACAG 39 and 59 CAAGGGCACTCAGACAGG 39. Internal
control beta-actin primers are 59 TGGCAAAGGGAGGTAG-
TTG 39 and 59GTGAGGAGGGCAAAGTGG 39.
Zebrafish (Danio rerio) maintenance
Wild type AB line and Tg(DeltaD:GAL4/UAS:Kaede) line
zebrafish were maintained according to methods described in The
Zebrafish Book (Westerfield, 1995). Details are provided in
Protocol S1.
Whole-mount in-situ hybridization
Procedure was followed by the method described in The
Zebrafish Book (Westerfield, 1995). Gene specific primers are: 59
TGCAAACGGAGGTAAAAACC 39 and 59AGATGATCCTGG-
TCCCACAG 39 for zlrrk2;5 9AAGGATGGCTTGGAGGAC39
and 59CTCGGAGGGTGGAGTAGA39 for th. PCR product was
cloned into pGEMT vector for probe synthesis. For dat,
59GGGGTTCAGTTCACCTCCTC39 and 59CATTAACCCT-
CACTAAAGGGAAGACTCCATCCCTCCCATAGC39 (with T3
promoter) were used for PCR and probe synthesis.
Morpholinos
Three different morpholino antisense oligonucleotides (transla-
tion start site of zlrrk2, ATG–ACAACTCCTCTATTTCTGC-
CATGAT; intron 45 splice donor junction; EI–CACAAGCA-
GATTTATTAACCTGTGC; intron 44 splice acceptor junction,
IE–GCTCCTGAAACACAGCATTAGGAAC) were obtained
from Gene Tools (Philomath, OR) and injected at the one- to
two-cell stage. Details of splicing interfering mopholino design are
provided in Protocol S1. Efficacy of morpholinos directed against
splice sites was evaluated using RT-PCR (Figure S5) with forward
primers F1-59TGCAAACGGAGGTAAAAACC 39 and in con-
junction with reverse primer R1- 59AGATGATCCTGGTCC-
CACAG 39. Dosage-dependent effects of morpholinos were
observed (Figure S4).
Northern analysis
Gene specific primers for probe synthesis are 59GTTG-
GCGTTCTGCCGGGT CC 39 and 59 AAAGCGGCCGCAT-
TAAGCAGCGTTTCTCTCATTCTGCGG 39. Details are pro-
vided in Protocol S1.
Western analysis
The anti-zLRRK2 antibody used in this study is developed from
the C-terminal (within WD40 domain, CSTRKPKVHSEDQSR)
regions of LRRK2. Western analysis was conducted using
standard techniques. Details are provided in Protocol S1 and
Figure S10. The truncated protein of zLRRK2-DWD40 cannot be
recognized by this antibody due to its absence of the WD40
domain.
Rescue experiments
For plasmid rescue, pCI-neo vector (Promega, USA) harbor-
ing zlrrk2 or hLRRK2 cDNAs tagged by Flag and hLRRK2
G2019S or G2385R cDNAs tagged by myc were used. At 2 to 3
days after the microinjection of the linearized plasmids by SfiI,
total fish homogenate was subjected to anti-Flag Western blot
analysis, clearly showing that both the zlrrk2 and hLRRK2
cDNAs could be expressed in zebrafish (Figure S7). Upon
confirming the expression of zlrrk2 and hLRRK2 cDNAs in
zebrafish, the rescue experiment was performed by the co-
microinjection of the plasmids and the ATG or splicing-blocking
morpholinos into embryos. Dosage-dependent effects of plasmid
over-expression were observed (Figure S4). For the rescue of the
ATG morphants, only the hLRRK2 cDNAs was used, because
the ATG morpholinos will block the protein expression of the
zlrrk2 cDNA.
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stage and behavior test was performed at 6 dpf.
Apoptosis assay
Apoptosis assay was carried out by using In Situ Cell Death
Detection Kit, TMR red (Roche).
Acetylated-tubulin staining on the brain
Procedures are referenced from Michael Hendricks and Suresh
Jesuthasan’s work [52]. Details are provided in Protocol S1.
Imaging and analysis
On a Zeiss LSM510 META confocal microscope, live embryos’
brains were imaged using an Achroplan 10X/0.30 water
immersion objective and alpha tubulin stained brains were imaged
using a EC Plan-Neofluar 10x/0.30 objective. Projection of
confocal z-stacks was done using Zeiss software.
Video recording for the behavior analysis of 6 dpf larva were
taken with a Sony HDR-SR12E. Behavior analysis was done using
NIH ImageJ.
Sequence conservation analysis
Protein domains of zebrafish LRRK2 were predicted by
SMART (Simple Modular Architecture Research Tool, http://
smart.embl-heidelberg.de). Each domains and whole protein of
zLRRK2 and hLRRK2 were aligned by ClustalW2 (http://www.
ebi.ac.uk/Tools/clustalw2/index.html).
Phylogenetic analysis
The animal protein sequences of the COR and Kinase domains
are obtained from Marin’s study [14]. Details are provided in
Protocol S1.
Supporting Information
Figure S1 Phylogenetic analysis of LRRK2 by using either
COR or kinase domain sequences.
Found at: doi:10.1371/journal.pgen.1000914.s001 (0.33 MB TIF)
Figure S2 Quantification analysis of the results in Figure 3A and
Figure S3A.
Found at: doi:10.1371/journal.pgen.1000914.s002 (0.39 MB TIF)
Figure S3 Phenotypes of zLRRK2 ATG morphants. (A)
Western blot analysis at 72 hpf showing the strong reduction in
expression of zLRRK2 protein as well as the decreased TH
protein level in embryos injected with ATG morpholino. The
analysis was done in duplicate, and adult brain protein was used as
positive control for zLRRK2. (B) WISH analysis at 2 dpf showing
retarded brain development and decreased TH expression in an
ATG morphant (right). An uninjected sibling is shown for
comparison (left). Quantification of the TH+ cell loss in ATG
morphant as well as the rescue of ATG morphant with hLRRK2
was shown on the right. Co-injection of hLRRK2 significantly
rescue the number of TH+ cells compared to ATG MO alone.
***P,0.001 (unpaired Student’s t-test). (C) Heart edema pheno-
type of ATG morphant and rescue effect of hLRRK2 on ATG
morphant.
Found at: doi:10.1371/journal.pgen.1000914.s003 (4.98 MB
TIF)
Figure S4 Dosage-dependent effect of morpholinos. (A) Dosage
dependent experiment of WD40 morpholino and lrrk2 plasmid
(zLRRK2, hLRRK2, hG2019S, and hG2385R) basing on the
phenotype of blood accumulation. (B) Dosage dependent exper-
iment of ATG morpholino basing on the quantification of TH+
cell loss. ***P,0.001 (unpaired Student’s t-test).
Found at: doi:10.1371/journal.pgen.1000914.s004 (1.01 MB TIF)
Figure S5 RT-PCR Analysis to confirm the blockage of exon 45
splicing by WD40 morpholino. (A) Schematic representation of
the exons 44 to 47 of zLRRK2 to show the morpholinos used for
blocking the 45th exon splicing (the track above the exons) as well
as the primers (the track below the exons) used in the RT-PCR
verification of the splicing blockage effect at 2 dpf and 3 dpf. (B)
RT-PCR analysis at 2 and 3 dpf showing that the WD40
morpholino could block the splicing of exon 45, and the major
of transcripts were the abnormally spliced one without exon 45
(confirmed by sequence analysis). (C) The percentage of the
normally spliced transcript in the total amount of normal and
abnormally spliced (without exon 45) transcripts in WT and
WD40 morphant at 2 and 3 dpf. The densities of normal and
abnormal spliced transcripts (in B) at 2 and 3 dpf were measured,
and the percentage of normally spliced transcript was calculated
by comparing the density of normal transcript to the total density
of both normal and abnormal transcripts (sum of density from
normal and abnormal forms). The percentage is presented as
mean 6 SD from 4 independent experiments. In wild-type
embryos, no abnormal splicing forms were detected. ***P,0.001
(unpaired Student’s t-test). (D) Quantitative RT-PCR analysis of
wild-type controls and WD40 morphants at 2 and 3 dpf, showing
that both TH and WT zLRRK2 mRNA levels were reduced to
40%–60% of WT fishes.
Found at: doi:10.1371/journal.pgen.1000914.s005 (0.26 MB TIF)
Figure S6 Morphological phenotype of WD40 morphants
(From 3 dpf to 7 dpf). Morphants show no significant morpho-
logical defects compared to WT fishes except the mild blood
accumulation in gut and pronephric duct between the york sac
and swimming bladder.
Found at: doi:10.1371/journal.pgen.1000914.s006 (0.91 MB TIF)
Figure S7 Linearized plasmid harboring either zLRRK2 or
hLRRK2 cDNA tagged by Flag can be expression in zebrafish
embryos by microinjection.
Found at: doi:10.1371/journal.pgen.1000914.s007 (0.04 MB TIF)
Figure S8 Swimming tracts of 15 fish from each of the five fish
pools: wild-type (wt), WD40 morphants (WD40), WD40 mor-
phants co-injected with plasmid harboring either zLRRK2
(WD40+zLRRK2) or hLRRK2 (WD40+hLRRK2) and WD40
morphants treated with levodopa (WD40+levodopa).
Found at: doi:10.1371/journal.pgen.1000914.s008 (0.81 MB TIF)
Figure S9 Morphological phenotype of hG2019S and hG2385R
overexpression. At 6 dpf, hG2019S and hG2385R overexpression
shows no significant morphological defects compared to WT
except the blood accumulation in gut and pronephric duct
between york sac and swimming bladder.
Found at: doi:10.1371/journal.pgen.1000914.s009 (0.60 MB TIF)
Figure S10 Analysis of zLRRK2 antibody specificity. (A)
Specificity of zLRRK2 antibody specificity was verified by western
blot analysis. Positive signals could be largely blocked by pre-
incubating the anti-zLRRK2 antibody with the neutralizing
peptide (+ peptide, left panel). Similarly, the zLRRK2 signal was
completely blocked by pre-incubating the anti-zLRRK2 antibody
with the neutralizing peptide in the zLRRK2-overexpressing Cos-
7 cells (+ peptide, right panel). (B) Western blot analysis showing
the specificity of the zLRRK2 antibody against zLRRK2 in Cos-7
cell line. Human LRRK2 and zLRRK2 recombinant proteins
were overexpressed in Cos-7 cells separately and detected by anti-
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A positive band (280 kD, arrow) was only detected in hLRRK2-
overexpressing cells (hLRRK2, left panel), using anti-hLRRK2
antibody (NOVUS NB 300–268). No obvious band was detected
in zLRRK2-overexpressing and untransfected control cells
(zLRRK2 and control, left panel); On the other hand, a sharp
band (arrow) was detected in zLRRK2-overexpressing cells using
the anti-zLRRK2 antibody (zLRRK2, right panel), but not in
hLRRK2-overexpressing and untransfected control cells
(hLRRK2 and control, right panel). This indicates the anti-
zLRRK2 antibody is specifically against zLRRK2 proteins.
Found at: doi:10.1371/journal.pgen.1000914.s010 (0.11 MB TIF)
Text S1 cDNA sequence and exon information of zLRRK2.
Found at: doi:10.1371/journal.pgen.1000914.s011 (0.09 MB
DOC)
Protocol S1 Supporting materials and methods.
Found at: doi:10.1371/journal.pgen.1000914.s012 (0.04 MB
DOC)
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